Hormone replacement therapy [topp]
C-reactive protein [aapp, imft]
Fibrinogen [aapp, bacs, phsu]
Health [idcn]
postmenopausal [tmco]
Women [popg]
Objective [inpr]
To [qlco]
investigate [ftcn]
Short-term [tmco]
Long-Term Effects [phpr]
Combined [qlco]
Hormone replacement therapy [topp]
C-reactive protein [aapp, imft]
Fibrinogen [aapp, bacs, phsu]
plasma concentration [qnco]
Health [idcn]
postmenopausal [tmco]
Women [popg]
Methods [inpr]
Cross-Sectional Study [resa]
Health [idcn]
postmenopausal [tmco]
Women [popg]
Women [popg]
Receive [qlco]
Following [tmco]
Treatments [topp]
Transdermal [ftcn]
medroxyprogesterone acetate [horm, phsu, strd]
N NOS [aapp, imft]
Oral [spco]
Norethisterone acetate [horm, phsu, strd]
N NOS [aapp, imft]
Conjugated Equine Estrogens [horm, phsu, strd]
medroxyprogesterone acetate [horm, phsu, strd]
N NOS [aapp, imft]
Same [qlco]
Combined therapy [topp]
Women [popg]
months [tmco]
Transdermal [ftcn]
medroxyprogesterone acetate [horm, phsu, strd]
N NOS [aapp, imft]
Oral [spco]
Norethisterone acetate [horm, phsu, strd]
N NOS [aapp, imft]
Conjugated Equine Estrogens [horm, phsu, strd]
medroxyprogesterone acetate [horm, phsu, strd]
N NOS [aapp, imft]
Control Group [grup]
included [ftcn]
Health [idcn]
postmenopausal [tmco]
Women [popg]
Not [ftcn]
Receive [qlco]
Hormone replacement therapy [topp]
Effect [qlco]
Type [qlco]
Duration [tmco]
Hormone replacement therapy [topp]
regimens [inpr]
Plasma [bdsu]
Level [qlco]
C-reactive protein [aapp, imft]
Fibrinogen [aapp, bacs, phsu]
Lipids [lipd]
investigated [ftcn]
Result [ftcn]
median [spco]
C-reactive protein [aapp, imft]
Concentrations [menp]
High [qlco]
Women [popg]
Receive [qlco]
Oral [spco]
Estradiol + norethindrone acetate [horm, phsu, strd]
P NOS [aapp, imft]
Conjugated Equine Estrogens [horm, phsu, strd]
medroxyprogesterone acetate [horm, phsu, strd]
P NOS [aapp, imft]
Women [popg]
Take [hlca]
Same [qlco]
Types [qlco]
Hormone replacement therapy [topp]
months [tmco]
Not [ftcn]
Hormone replacement therapy [topp]
median [spco]
C-reactive protein level [lbpr]
Similar [qlco]
Women [popg]
Take [hlca]
Transdermal [ftcn]
medroxyprogesterone acetate [horm, phsu, strd]
months [tmco]
Compared [acty]
Control [grup]
fibrinogen levels [lbpr]
Not [ftcn]
Different [qlco]
Group [idcn]
Hormone replacement therapy [topp]
Users [humn]
Conclusions [idcn]
Elevated [qlco]
Levels [qlco]
C-reactive protein [aapp, imft]
APPEAR [qlco]
Very [qlco]
Recently [tmco]
Marker [clna]
Cardiovascular disease [dsyn]
Responsible [fndg]
Early [tmco]
Increased [qnco]
CARDIOVASCULAR [bdsy]
Risk [qlco]
Start [tmco]
Oral [spco]
Combined [qlco]
Hormone replacement therapy [topp]
Increased [qnco]
Risk [qlco]
Early [tmco]
To [qlco]
Decrease [qlco]
Long-term [tmco]
Transdermal [ftcn]
medroxyprogesterone acetate [horm, phsu, strd]
Effect [qlco]
C-reactive protein [aapp, imft]
Short-term [tmco]
Long-term [tmco]
[c] [qnco]
Ireland [geoa]
LTD [ortf]
Rights [qlco]
Reserve [acty]
